Posted in | News

AECOM JV Team Wins Eight-Year Program-Management Contract from MTA

AECOM Technology Corporation (NYSE: ACM), a leading provider of professional technical and management support services for government and commercial clients around the world, announced today that a joint venture in which it participates with Rummler, Klepper & Kahl LLP has been awarded an eight-year, US$60-million program-management contract by the Maryland Transit Administration (MTA) of the Maryland Department of Transportation.

The work is for the program management of major capital projects in Maryland involving new mass transit initiatives, including the Red Line, the Purple Line and the Corridor Cities Transitway light rail projects, which are currently in the planning and environmental phases of project development.

"We are excited to play a key role in expanding and revitalizing Maryland’s public transportation system," said John M. Dionisio, AECOM president and chief executive officer.

Under the contract, the joint venture team will be responsible for project management of the Purple Line as well as systems preservation, enhancement and expansion for all of MTA’s existing transport modes, including bus, metro subway, light rail, Maryland Area Regional Commuter Rail, commuter bus, paratransit and freight. The team will finalize planning and preliminary engineering activities, oversee final design and pre-construction work, and provide construction management/inspection, quality assurance/quality control, and systems start-up services.

Project works are expected to be completed over an eight-year period.

Source: http://www.aecom.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.